Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
In September, 1983, a group of French and American experts met at the French National Health Laboratory to discuss their experience in monitoring for the safety of a hepatitis B vaccine in 42 chimpanzees. The observations made, conclusions reached, and recommendations for future studies are presented.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology*; D008099:Liver / Q000473:pathology; D009336:Necrosis; D002679:Pan troglodytes; D011790:Quarantine; D014611:Vaccination / Q000592:standards*; D014761:Viral Hepatitis Vaccines / Q000592:standards*; D014944:World Health Organization
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase